🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Retinal vasculitis - By Charles-Antoine Dallevet (fellow in Internal Medicine, Paris, France) #vasculitis #retinal #InternistAcademy 2024

#JAKi for #GCA - exciting new development! #vasculitis #upadacitinib

To taper or not to taper - #glucocorticoids #vasculitis #AAV Results of the TAPIR trial

Great summary of #treatment goals in #GCA #vasculitis by ⁦Milena Bond⁩ #ACR24

⁦⁦Christian Dejaco⁩ asks an important question in the management of #GCA #vasculitis If a patient goes into sustained remission with therapy, but then develops an aortic #aneurysm - is that considered a treatment response?

Congratulations Alí Duarte, MD !

Congratulations ⁦Mahmut Kaymakci, MD⁩ Recipient of the 2024 Hunder Award in #Vasculitis research ⁦Mayo Clinic⁩ #ACR2024 Proud mentor moment!

Systemic polyarteritis nodosa looks creepily/scarily beautiful on PET/CT. Look at that Christmas tree! but sensitivity can be affected by pred, & isn't great even without (48%). By itself, a good rule in test, but not a good rule out test. #ACR24 ABST1962 Mayo Clinic Dr. John Cush

Sullivan et al. Vasculitis in VEXAS. 81 patients. 27% vasculitis. Cutaneous SVV 20%, AAV 2.5%, cutaneous MVV 2.5%, LVV 2.5%. Dr. John Cush #ACR24 Abstr#2651 acrabstracts.org/abstract/vascu…

🚨Check out our latest work on vasculitic myopathy Neurology Journal! A fantastic collaboration between Mayo Clinic Neuro and #MayoRheum. Thank you, Elie Naddaf, for the incredible mentorship, and KenWarringtonMD and #MattKoster for the help. Breakdown ⬇️ 1/7 neurology.org/doi/pdf/10.121…

Website's up! vasculitis-melbourne2026.com All things #vasculitis in Melbourne Feb 2026. Key dates, things to do and promotional tools, with more to follow Come for exceptional research, learning and interactions over 5 days And....a great trip to Australia and New Zealand!

Rheum consults on #Christmas Eve - from #gout to #vasculitis to #myositis Mayo Clinic

Expert Perspectives on Clinical Challenges: Management of Relapses in Giant Cell Arteritis In Arthritis & Rheumatology doi.org/10.1002/art.43…

Just going through photos from the past couple years. This is part of the coastline of Malta. One of the most incredible and unique places to visit. History around every turn. I love the place.

Looking forward to speaking about #vasculitis - General concepts at this informative conference!

#vasculitis #GCA #imaging #PAD Mayo Clinic

Important publication on Treatment of Giant Cell Arteritis (GCA). "In patients with GCA, upadacitinib at a dose of 15 mg with a 26-week GCs taper showed efficacy superior to that of PBO with a 52-week GC taper. nejm.org/doi/pdf/10.105…

Great discussion with an amazing group!

FDA has approved upadacitinib (Rinvoq) for treatment of adults with Giant Cell Arteritis (GCA). This is the 9th indication for the drug. investingnews.com/rinvoq-r-recei…

JAKing down glucocorticoids in giant cell arteritis sciencedirect.com/science/articl… #GCA #JAKi #treatment #mayoclinicrheumatology